GGrantIndex
← Leaderboards

Scott Powers

Amplicon Corporation

$21,823,105
Attributed
$22,022,844
Total exposure
9
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.2M · FY200721
$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21

Funding mix

By agency

NIH$22,022,844 · 9

By mechanism

U01$7,270,912 · 1
R01$4,974,415 · 2
RC2$4,737,965 · 1
P01$4,540,073 · 3
R21$399,479 · 1
R43$100,000 · 1

Top collaborators

Others in their field

Top investigators on “Technology

Research focus

TechnologyGenomicsGenesBaseBiologicalInnovationTumorMalignant NeoplasmsStem CellsData SetRna InterferenceCommunitiesProgramsOncogenesMemberOncogenicSuccessAreaIn VivoProteomicsLaboratoriesGene ExpressionProteinsSmall Hairpin Rna

Grant awards (34)

Multigenic copy number alterations$553,157
R01 · FY2021 · CA · contact PI
Multigenic copy number alterations$603,321
R01 · FY2020 · CA · contact PI
Multigenic copy number alterations$536,561
R01 · FY2019 · CA · contact PI
Supplement to Multigenic copy number alterations$40,159
R01 · FY2019 · CA · contact PI
Multigenic copy number alterations$553,157
R01 · FY2018 · CA · contact PI
Multigenic copy number alterations$552,016
R01 · FY2017 · CA · contact PI
Core D$206,649
P01 · FY2017 · CA · contact PI
High-throughput genetic interaction sequencing in mammalian cells$200,361
R21 · FY2017 · HG · contact PI
COMPUTATIONAL AND FUNCTIONAL APPROACHES TO VALIDATING CANCER GENOME TARGETS$1,420,487
U01 · FY2016 · CA · contact PI
Core D$460,702
P01 · FY2016 · CA · contact PI
High-throughput genetic interaction sequencing in mammalian cells$199,118
R21 · FY2016 · HG · contact PI
COMPUTATIONAL AND FUNCTIONAL APPROACHES TO VALIDATING CANCER GENOME TARGETS$70,071
U01 · FY2016 · CA · contact PI
COMPUTATIONAL AND FUNCTIONAL APPROACHES TO VALIDATING CANCER GENOME TARGETS$1,420,487
U01 · FY2015 · CA · contact PI
Core D$459,844
P01 · FY2015 · CA · contact PI
COMPUTATIONAL AND FUNCTIONAL APPROACHES TO VALIDATING CANCER GENOME TARGETS$1,397,036
U01 · FY2014 · CA · contact PI
Core D$434,199
P01 · FY2014 · CA · contact PI
COMPUTATIONAL AND FUNCTIONAL APPROACHES TO VALIDATING CANCER GENOME TARGETS$1,307,258
U01 · FY2013 · CA · contact PI
Core D$425,521
P01 · FY2013 · CA · contact PI
COMPUTATIONAL AND FUNCTIONAL APPROACHES TO VALIDATING CANCER GENOME TARGETS$250,000
U01 · FY2013 · CA · contact PI
COMPUTATIONAL AND FUNCTIONAL APPROACHES TO VALIDATING CANCER GENOME TARGETS$1,405,573
U01 · FY2012 · CA · contact PI
Genomics and Proteomics$443,355
P01 · FY2012 · CA · contact PI
Genomics and Proteomic Analysis$474,930
P01 · FY2011 · CA · contact PI
An integrative approach to cancer gene discovery in hepatocellular carcinoma$435,619
R01 · FY2011 · CA · contact PI
CSHL Molecular Target Discovery and Development Center$2,374,043
RC2 · FY2010 · CA · contact PI
An integrative approach to cancer gene discovery in hepatocellular carcinoma$435,804
R01 · FY2010 · CA · contact PI
Genomics and Proteomic Analysis$433,217
P01 · FY2010 · CA · contact PI
CSHL Molecular Target Discovery and Development Center$2,363,922
RC2 · FY2009 · CA · contact PI
An integrative approach to cancer gene discovery in hepatocellular carcinoma$429,479
R01 · FY2009 · CA · contact PI
Genomics and Proteomic Analysis$411,516
P01 · FY2009 · CA · contact PI
An integrative approach to cancer gene discovery in hepatocellular carcinoma$419,084
R01 · FY2008 · CA · contact PI
Genomics and Proteomic Analysis$415,535
P01 · FY2008 · CA · contact PI
An integrative approach to cancer gene discovery in hepatocellular carcinoma$416,058
R01 · FY2007 · CA · contact PI
Genomics and Proteomic Analysis$374,605
P01 · FY2007 · CA · contact PI
ANTIBODIES TO NEW AMPLIFIED BREAST CANCER GENE PRODUCTS$100,000
R43 · FY2000 · CA